↓ Skip to main content

Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, May 2013
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#14 of 2,578)
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
2 news outlets
blogs
3 blogs
twitter
22 X users
patent
3 patents
facebook
5 Facebook pages

Citations

dimensions_citation
201 Dimensions

Readers on

mendeley
213 Mendeley